---
$id: https://graph.org.ai/products/commodity/51442442
$type: Product
source: UNSPSC
code: "51442442"
title: "Ioversol"
class: "51442400"
classTitle: "Iodine-based radiopharmaceuticals, imaging agents, media, and tracers"
family: "51440000"
familyTitle: "Radiopharmaceuticals and contrast media"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ioversol

**UNSPSC Code**: 51442442
**Class**: [Iodine-based radiopharmaceuticals, imaging agents, media, and tracers](Iodine-based radiopharmaceuticals, imaging agents, media, and tracers.mdx)
**Family**: [Radiopharmaceuticals and contrast media](../Radiopharmaceuticals and contrast media.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an iodinated contrast dye with the molecular formula C18H24I3N3O9, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier N3RIB7X24K, chemically known as 1,3-benzenedicarboxamide, n,n-bis(2,3-dihydroxypropyl)-5-((hydroxyacetyl)(2-hydroxyethyl)amino)-2,4,6-triiodo- but more generally known as ioversol, which bears U.S. National Institutes of Health Compound Identifier 3741. European Medicines Agency schedules Ioversol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08262MIG. The term IOVERSOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules ioversol in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. IOVERSOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

